STERIS plc

STE 10-Q · Q1 2026
API behind this page

STE Q1 2026 request

Playground key active
Request URL /api/financials?ticker=STE&year=2026&quarter=1
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 1,391.1 1,279.5 +8.7%
Show Product Lines breakouts
Capital equipment · Applied Sterilization Technologies 1.6 1.1 +45.5%
Capital equipment · Healthcare Segment 227.3 214.6 +5.9%
Capital equipment · Life Science Member [Member] 26.6 26.5 +0.4%
Consumables · Healthcare Segment 358.9 343.4 +4.5%
Consumables · Life Science Member [Member] 75.3 69.8 +7.9%
Product 690.5 656.3 +5.2%
Service 700.6 623.2 +12.4%
Service · Applied Sterilization Technologies 279.6 248.7 +12.4%
Service · Healthcare Segment 388.5 343.2 +13.2%
Service · Life Science Member [Member] 33.3 32.2 +3.4%
Show Business Segments breakouts
Applied Sterilization Technologies 281.2 249.8 +12.6%
Applied Sterilization Technologies · Operating Segments 281.2 249.8 +12.6%
Healthcare Segment 974.7 901.2 +8.2%
Healthcare · Operating Segments 974.7 901.2 +8.2%
Life Science Member [Member] 135.2 128.5 +5.2%
Life Science Member [Member] · Operating Segments 135.2 128.5 +5.2%
Show Geography breakouts
IE 22.5 22.2 +1.4%
Other foreign locations 342.9 310.4 +10.5%
US 1,025.6 946.9 +8.3%
Cost of Revenue (Q) — — —
Show Product Lines breakouts
Product 359.7 340.4 +5.7%
Service 403.4 366.7 +10.0%
Cost of Revenue 763.1 707.1 +7.9%
Show Business Segments breakouts
Applied Sterilization Technologies · Operating Segments 129.9 115.9 +12.1%
Healthcare · Operating Segments 557.4 511 +9.1%
Life Science Member [Member] · Operating Segments 58 58.9 -1.5%
Gross Profit 628 572.4 +9.7%
Selling, General & Administrative 353.8 335.6 +5.4%
Show Business Segments breakouts
Applied Sterilization Technologies · Operating Segments 13.7 15.4 -11.0%
Healthcare · Operating Segments 159.1 150.9 +5.4%
Life Science Member [Member] · Operating Segments 16 14.8 +8.1%
Research & Development 26.4 25.6 +3.1%
Show Business Segments breakouts
Applied Sterilization Technologies · Operating Segments 0.9 0.7 +28.6%
Healthcare · Operating Segments 22.7 22.4 +1.3%
Life Science Member [Member] · Operating Segments 2.4 2.2 +9.1%
Restructuring Costs 1.8 25.7 -93.0%
Operating Expenses 382 386.9 -1.3%
Operating Income 246 185.5 +32.6%
Interest Expense 15.9 30.4 -47.7%
Other Non-Operating Income (Expense) -1.8 -1.3 -38.5%
Non-Operating Income (Expense) 14.1 10.3 +36.9%
Income Before Taxes 231.9 175.2 +32.4%
Income Tax Expense (Benefit) 53.9 35.3 +52.7%
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest 178 139.9 +27.2%
Net Income 178 145.5 +22.3%
Show Equity Components breakouts
Noncontrolling Interest 0.6 0.1 +500.0%
Retained Earnings 177.4 145.4 +22.0%
Net Income Loss Attributable To Noncontrolling Interest 0.6 0.1 +500.0%
Net Income 177.4 145.4 +22.0%
Income Loss From Continuing Operations Per Basic Share 1.8 1.41 +27.7%
EPS (Basic) 1.8 1.47 +22.4%
Income Loss From Continuing Operations Per Diluted Share 1.79 1.41 +27.0%
EPS (Diluted) 1.79 1.46 +22.6%
Common Stock Dividends Per Share Declared 0.57 0.52 +9.6%
Comprehensive Income 399.2 151 +164.4%
Other Comprehensive Income 221.8 5.6 +3860.7%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 221.8 5.6 +3860.7%
Wtd Avg Shares (Basic) 98.4 98.9 -0.5%
Wtd Avg Shares (Diluted) 98.8 99.4 -0.6%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 279.7 198,328 -99.9%
Accounts Receivable 947.1 892,606 -99.9%
Inventory 641.2 698,587 -99.9%
Other Prepaid Expense Current 189.8 150,973 -99.9%
Total Current Assets 2,057.8 1,940,494 -99.9%
Non-Current Assets
Property, Plant & Equipment 2,054.8 — —
Show Geography breakouts
IE 82.4 — —
Other Foreign Entities [Member] 928.1 — —
US 1,044.3 — —
Operating Lease Right-of-Use Assets 163.5 — —
Goodwill 4,223.1 — —
Other Non-Current Assets 88.6 63,127 -99.9%
Total Assets 10,405 — —
Show Business Segments breakouts
Applied Sterilization Technologies · Segment Continuing Operations 3,547.2 — —
Healthcare Products and Life Sciences · Segment Continuing Operations 6,857.8 — —
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 10,405 — —
Other Assets
Intangible Assets Net Excluding Goodwill 1,817.2 2,048,990 -99.9%
Current Liabilities
Accounts Payable 300.9 231,720 -99.9%
Accrued Income Taxes Current 64.7 57,000 -99.9%
Employee Related Liabilities Current 154.7 149,372 -99.9%
Operating Lease Liability Current 35.3 29,705 -99.9%
Accrued Liabilities 371 286,563 -99.9%
Total Current Liabilities 926.6 834,360 -99.9%
Non-Current Liabilities
Long-Term Debt 1,903.1 2,235,601 -99.9%
Deferred Income Taxes And Other Tax Liabilities Noncurrent 411.4 456,465 -99.9%
Operating And Finance Lease Obligation Noncurrent 130.4 139,362 -99.9%
Other Non-Current Liabilities 63.6 72,368 -99.9%
Total Liabilities 3,435.1 3,738,156 -99.9%
Long-Term Debt 1,903.1 — —
Accrued Income Taxes Noncurrent 1.9 6,427 -100.0%
Other Liabilities
Minority Interest 12.9 — —
Stockholders' Equity
Common Stock 4,431 4,499,580 -99.9%
Retained Earnings 2,596.5 2,178,087 -99.9%
Accumulated Other Comprehensive Income -70.5 — —
Total Stockholders' Equity 6,957 — —
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6,969.9 6,370.4 +9.4%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -0.6 -0.9 +33.3%
Accumulated Other Comprehensive Income -70.5 -323.1 +78.2%
Accumulated Translation Adjustment -69.9 -322.2 +78.3%
Common Stock 4,431 4,499.6 -1.5%
Noncontrolling Interest 12.9 15.8 -18.4%
Retained Earnings 2,596.5 2,178.1 +19.2%
Total Liabilities & Equity 10,405 10,108,601 -99.9%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Depreciation & Amortization 119.4 112.7 +5.9%
Show Business Segments breakouts
Applied Sterilization Technologies · Segment Continuing Operations 36.3 32.5 +11.7%
Healthcare Products and Life Sciences · Segment Continuing Operations 83.1 80.2 +3.6%
Show Statement Operating Activities Segment breakouts
Segment Continuing Operations 119.4 112.7 +5.9%
Stock-Based Compensation 11.9 11.5 +3.5%
Other Non-Cash Items 14.5 -2.5 +680.0%
Change in Accounts Receivable 119.2 107.7 +10.7%
Change in Inventory -42.5 -34.1 -24.6%
Change in Prepaid & Other Assets 18.9 9.4 +101.1%
Change in Accounts Payable 9.8 -17.1 +157.3%
Increase Decrease In Accrued Liabilities -9.2 1.5 -713.3%
Net Cash from Operations 420 303.7 +38.3%
Investing Activities
Capital Expenditures -93.6 -108.1 +13.4%
Proceeds From Sale Of Property Plant And Equipment 0.1 — —
Payments To Acquire Businesses Net Of Cash Acquired -15 -13.7 -9.5%
Show Business Acquisition breakouts
Other FY26 Acquisitions -15 — —
Net Cash from Investing -108.5 687.8 -115.8%
Financing Activities
Repayments Of Senior Debt -125 — —
Proceeds From Repayments Of Lines Of Credit -30.5 -253.2 +88.0%
Payments Of Merger Related Costs Financing Activities -0.1 -0.1 0.0%
Share Repurchases -10.6 -64.2 +83.5%
Payments Of Dividends Common Stock -56.2 -51.4 -9.3%
Proceeds From Payments For Other Financing Activities 9.3 5.6 +66.1%
Net Cash from Financing -213.1 -998.9 +78.7%
Tax Withholding for Share Compensation 10.6 10.3 +2.9%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 9.6 -1.3 +838.5%
Net Change in Cash 108 -8.7 +1341.4%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 279.7 198.3 +41.0%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key